The Valley Desk

ReviewFrontiers in oncologyPublished

Clinical efficacy and safety of pembrolizumab and nivolumab in frontline treatment for classical Hodgkin lymphoma: systematic review and meta-analysis of clinical trials

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source

Publication record

Type
Review
Venue
Frontiers in oncology
Published
Subject terms
Immunotherapy; PD-1; Hodgkin Lymphoma; Nivolumab; Immune Checkpoint Inhibitors; Pembrolizumab
PubMed ID
42434738
PubMed Central ID
PMC13349832
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal